Rigel Pharmaceuticals, Inc. (RIGL)

NASDAQ: RIGL · Real-Time Price · USD

45.95

-1.30 (-2.75%)

At close: Oct 16, 2026, 4:00 PM EDT

45.97

+0.02 (0.04%)

After-hours: Oct 16, 2026, 4:10 PM EDT

Rigel Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	276.52	294.02	179.28	115.78	115.74	138.74
Other Revenue	0.27	0.27	-	1.1	-	-
Revenue	276.79	294.28	179.28	116.88	115.74	138.74
Revenue Growth	3.31%	64.15%	53.38%	0.98%	-16.57%	27.73%
Cost of Revenue	67.51	52.92	42.03	31.63	62.02	66.32
Gross Profit	209.27	241.37	137.25	85.25	53.72	72.42
Selling, General & Admin	122.22	115.9	113.06	105.74	112.45	91.89
Operating Expenses	122.22	115.9	113.06	105.74	112.45	91.89
Operating Income	87.05	125.47	24.19	-20.49	-58.73	-19.48
Interest Expense	-5.81	-7.32	-7.92	-6.87	-3.71	-4.86
Interest & Investment Income	4.33	3.68	2.09	2.27	0.68	0.05
EBT Excluding Unusual Items	85.58	121.83	18.37	-25.09	-61.75	-24.29
Merger & Restructuring Charges	-	-	-	-	-1.32	-3.52
Other Unusual Items	-	-	-	-	4.5	10.5
Pretax Income	85.58	121.83	18.37	-25.09	-58.57	-17.31
Income Tax Expense	-236.33	-245.2	0.88	-	-	0.61
Net Income	321.91	367.02	17.49	-25.09	-58.57	-17.91
Net Income to Common	321.91	367.02	17.49	-25.09	-58.57	-17.91
Net Income Growth	229.08%	1999.08%	-	-	-	-
Shares Outstanding (Basic)	18	18	18	17	17	17
Shares Outstanding (Diluted)	20	19	18	17	17	17
Shares Change	8.67%	6.52%	1.64%	2.07%	-0.00%	1.03%
EPS (Basic)	17.59	20.40	0.99	-1.44	-3.44	-1.05
EPS (Diluted)	16.45	19.48	0.99	-1.44	-3.44	-1.05
EPS Growth	202.71%	1867.68%	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	79.39	75.66	31.44	-5.74	-74.21	5.25
Free Cash Flow Per Share	4.06	4.02	1.78	-0.33	-4.35	0.31
Gross Margin	75.61%	82.02%	76.56%	72.94%	46.41%	52.20%
Operating Margin	31.45%	42.63%	13.49%	-17.53%	-50.74%	-14.04%
Profit Margin	116.30%	124.72%	9.75%	-21.47%	-50.61%	-12.91%
Free Cash Flow Margin	28.68%	25.71%	17.53%	-4.91%	-64.11%	3.79%
EBITDA	89.7	127.88	26.42	-19.25	-57.73	-18.31
EBITDA Margin	32.41%	43.45%	14.74%	-16.47%	-49.88%	-13.20%
D&A For EBITDA	2.65	2.42	2.23	1.24	1	1.16
EBIT	87.05	125.47	24.19	-20.49	-58.73	-19.48
EBIT Margin	31.45%	42.63%	13.49%	-17.53%	-50.74%	-14.04%
Effective Tax Rate	-	-	4.80%	-	-	-
Revenue as Reported	276.79	294.28	179.28	116.88	120.24	149.24
Advertising Expenses	-	2.3	2.1	3.1	-	-

SEC Filings: 10-K · 10-Q